Characterization of the nasopharyngeal carcinoma methylome identifies aberrant disruption of key signaling pathways and methylated tumor suppressor genes.

AIMS Nasopharyngeal carcinoma (NPC) is a common tumor consistently associated with Epstein-Barr virus infection and prevalent in South China, including Hong Kong, and southeast Asia. Current genomic sequencing studies found only rare mutations in NPC, indicating its critical epigenetic etiology, while no epigenome exists for NPC as yet. MATERIALS & METHODS We profiled the methylomes of NPC cell lines and primary tumors, together with normal nasopharyngeal epithelial cells, using methylated DNA immunoprecipitation (MeDIP). RESULTS We observed extensive, genome-wide methylation of cellular genes. Epigenetic disruption of Wnt, MAPK, TGF-β and Hedgehog signaling pathways was detected. Methylation of Wnt signaling regulators (SFRP1, 2, 4 and 5, DACT2, DKK2 and DKK3) was frequently detected in tumor and nasal swab samples from NPC patients. Functional studies showed that these genes are bona fide tumor-suppressor genes for NPC. CONCLUSION The NPC methylome shows a special high-degree CpG methylation epigenotype, similar to the Epstein-Barr virus-infected gastric cancer, indicating a critical epigenetic etiology for NPC pathogenesis.

[1]  D. Kwong,et al.  Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation‐sensitive high resolution melting , 2015, International journal of cancer.

[2]  Lanlan Shen,et al.  Targeted p16(Ink4a) epimutation causes tumorigenesis and reduces survival in mice. , 2014, The Journal of clinical investigation.

[3]  S. Ogawa,et al.  The genomic landscape of nasopharyngeal carcinoma , 2014, Nature Genetics.

[4]  F. Yang,et al.  A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth , 2014, Oncogene.

[5]  K. Yao,et al.  Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker. , 2014, Oncology reports.

[6]  R. Irizarry,et al.  Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population , 2014, Epigenetics.

[7]  Gianluca Bontempi,et al.  A comprehensive overview of Infinium HumanMethylation450 data processing , 2013, Briefings Bioinform..

[8]  X. Guan,et al.  Characterization of CACNA2D3 as a putative tumor suppressor gene in the development and progression of nasopharyngeal carcinoma , 2013, International journal of cancer.

[9]  Song Zhang,et al.  Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma , 2013, Cancer Cell International.

[10]  Jun Yu,et al.  The Metalloprotease ADAMTS8 Displays Antitumor Properties through Antagonizing EGFR–MEK–ERK Signaling and Is Silenced in Carcinomas by CpG Methylation , 2013, Molecular Cancer Research.

[11]  Q. Tao,et al.  FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. , 2013, Carcinogenesis.

[12]  Q. Tao,et al.  Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cells , 2013, Journal of cellular and molecular medicine.

[13]  J. Sung,et al.  ADAMTS9 is a functional tumor suppressor through inhibiting AKT/mTOR pathway and associated with poor survival in gastric cancer , 2013, Oncogene.

[14]  Brandilyn A. Peters,et al.  Batch Effects and Pathway Analysis: Two Potential Perils in Cancer Studies Involving DNA Methylation Array Analysis , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[15]  G. Lang,et al.  Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. , 2013, Carcinogenesis.

[16]  R. Weksberg,et al.  Discovery of cross-reactive probes and polymorphic CpGs in the Illumina Infinium HumanMethylation450 microarray , 2013, Epigenetics.

[17]  Cancer research in an era when epigenetics is no longer “epi”—challenges and opportunities , 2013, Chinese journal of cancer.

[18]  Q. Tao,et al.  Epigenetic identification of receptor tyrosine kinase-like orphan receptor 2 as a functional tumor suppressor inhibiting β-catenin and AKT signaling but frequently methylated in common carcinomas , 2013, Cellular and Molecular Life Sciences.

[19]  Q. Tao,et al.  DACT1, an antagonist to Wnt/β-catenin signaling, suppresses tumor cell growth and is frequently silenced in breast cancer , 2013, Breast Cancer Research.

[20]  Xiuqing Zhang,et al.  Double restriction-enzyme digestion improves the coverage and accuracy of genome-wide CpG methylation profiling by reduced representation bisulfite sequencing , 2013, BMC Genomics.

[21]  G. Ren,et al.  Protocadherin8 is a functional tumor suppressor frequently inactivated by promoter methylation in nasopharyngeal carcinoma , 2012, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[22]  Zhe Zhang,et al.  Promoter hypermethylation of Ras-related GTPase gene RRAD inactivates a tumor suppressor function in nasopharyngeal carcinoma. , 2012, Cancer letters.

[23]  J. Inazawa,et al.  Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor suppressor in hepatocellular carcinoma. , 2012, Clinical cancer research : an official journal of the American Association for Cancer Research.

[24]  R. Ben Gacem,et al.  Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[25]  W. Jia,et al.  Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma. , 2012, Seminars in cancer biology.

[26]  K. To,et al.  Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. , 2012, Seminars in cancer biology.

[27]  Yuan Zhang,et al.  The human cadherin 11 is a pro-apoptotic tumor suppressor modulating cell stemness through Wnt/β-catenin signaling and silenced in common carcinomas , 2011, Oncogene.

[28]  E. Zabarovsky,et al.  Tumor suppressor dual‐specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial‐mesenchymal transition (EMT)‐associated phenotype , 2012, International journal of cancer.

[29]  Q. Tao,et al.  Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins , 2012, BMC Cancer.

[30]  H. Aburatani,et al.  Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. , 2011, Cancer research.

[31]  Zhe Zhang,et al.  CDH4 as a novel putative tumor suppressor gene epigenetically silenced by promoter hypermethylation in nasopharyngeal carcinoma. , 2011, Cancer Letters.

[32]  Q. Tao,et al.  A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors , 2011, Oncogene.

[33]  Q. Tao,et al.  Epigenetic disruption of cell signaling in nasopharyngeal carcinoma , 2011, Chinese journal of cancer.

[34]  N Clarke,et al.  Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma , 2011, Oncogene.

[35]  J. Califano,et al.  A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma , 2011, International journal of cancer.

[36]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[37]  Jaap M Middeldorp,et al.  Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population , 2011, Molecular Cancer.

[38]  Arvindhan G. Nagarajan,et al.  Advances in genome-wide DNA methylation analysis. , 2010, BioTechniques.

[39]  Andrew P. Feinberg,et al.  Epigenomics Reveals a Functional Genome Anatomy and a New Approach to Common Disease , 2010, Nature Biotechnology.

[40]  T. Fukagawa,et al.  KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. , 2010, Cancer research.

[41]  E. Liu,et al.  A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci , 2010, Nature Genetics.

[42]  W. Jia,et al.  The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma , 2010, Clinical Cancer Research.

[43]  O. Rennert,et al.  Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer , 2010, British Journal of Cancer.

[44]  Ngan-Ming Tsang,et al.  Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. , 2009, American journal of human genetics.

[45]  Wei Zheng,et al.  CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis. , 2009, Cancer research.

[46]  E. Liu,et al.  Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. , 2008, Cancer research.

[47]  M. Lung,et al.  Epigenetic disruption of interferon-γ response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas , 2008, Oncogene.

[48]  A. Cheung,et al.  Expression of concern: Characterization of a novel epigenetically‐silenced, growth‐suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma , 2008, International journal of cancer.

[49]  R. Durbin,et al.  A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis , 2008, Nature Biotechnology.

[50]  Qiang Yu,et al.  DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. , 2008, Cancer cell.

[51]  A. Mutirangura,et al.  Promoter hypermethylation of CCNA1, RARRES1, and HRASLS3 in nasopharyngeal carcinoma. , 2008, Oral oncology.

[52]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[53]  Zhong-ying Shen,et al.  Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas , 2007, Oncogene.

[54]  Jun Yu,et al.  Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer , 2007, British Journal of Cancer.

[55]  Zhong-ying Shen,et al.  Epigenetic silencing of a Ca2+-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers , 2007, Proceedings of the National Academy of Sciences.

[56]  G. Srivastava,et al.  The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas , 2007, Laboratory Investigation.

[57]  Q. Tao,et al.  Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments , 2007, Expert Reviews in Molecular Medicine.

[58]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[59]  J. Califano,et al.  The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation , 2007, Oncogene.

[60]  P. Meltzer,et al.  Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase , 2006, International journal of cancer.

[61]  Q. Tao,et al.  Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics. , 2006, Frontiers in bioscience : a journal and virtual library.

[62]  H. Fujii,et al.  CpG Island M`ethylation Status in Gastric Carcinoma with and without Infection of Epstein-Barr Virus , 2006, Clinical Cancer Research.

[63]  T. Putti,et al.  Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation , 2006, Oncogene.

[64]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[65]  Q. Tao,et al.  Frequent Hypermethylation of RASSF1A, TSLC1, High Viral Load of Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma, Matched Tumor-Adjacent Tissues , 2005 .

[66]  H. Cheung,et al.  Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation , 2005, Molecular carcinogenesis.

[67]  W. Lam,et al.  Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.

[68]  Q. Tao,et al.  Frequent hypermethylation of RASSF1A and TSLC1, and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues. , 2005, Neoplasia.

[69]  E. Liu,et al.  Fine mapping of the 11q22–23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma , 2004, International journal of cancer.

[70]  L. Young,et al.  Epstein–Barr virus: 40 years on , 2004, Nature Reviews Cancer.

[71]  Qian Tao,et al.  The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma , 2004, Oncogene.

[72]  Kwok Wai Lo,et al.  Focus on nasopharyngeal carcinoma. , 2004, Cancer cell.

[73]  A. Hui,et al.  Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma , 2003, Molecular carcinogenesis.

[74]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[75]  D. Kwong,et al.  Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[76]  D. Kwong,et al.  Differential gene methylation in undifferentiated nasopharyngeal carcinoma. , 2003, International journal of oncology.

[77]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[78]  N. Raab-Traub Epstein-Barr virus in the pathogenesis of NPC. , 2002, Seminars in cancer biology.

[79]  Q. Tao,et al.  Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. , 2002, Human molecular genetics.

[80]  Yan Fang,et al.  Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4 , 2002, Nature Genetics.

[81]  S. Tsao,et al.  Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes. , 2002, Biochimica et biophysica acta.

[82]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[83]  M. Rhyu,et al.  Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. , 2002, The American journal of pathology.

[84]  P. Johnson,et al.  Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[85]  J. Kwong,et al.  High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. , 2001, Cancer research.

[86]  N. Raab-Traub,et al.  Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma , 2000, International journal of cancer.

[87]  A. Wolffe,et al.  Epigenetics: regulation through repression. , 1999, Science.

[88]  S. Cheung,et al.  Nasopharyngeal carcinoma cell line (C666‐1) consistently harbouring Epstein‐Barr virus , 1999, International journal of cancer.

[89]  Q. Tao,et al.  Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis. , 1999, The American journal of pathology.

[90]  S. Leung,et al.  Hypermethylation of the p16 gene in nasopharyngeal carcinoma. , 1996, Cancer research.

[91]  E. Kieff Epstein-Barr virus and its replication , 1996 .

[92]  M. Lipinski,et al.  Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas , 1988, International journal of cancer.

[93]  H. Maruyama,et al.  Functional , 2020, Congress of Neurological Surgeons Essent.